Flaviviruses infect hundreds of millions of people annually, and no antiviral therapy is available 1,2 . We performed a genome-wide CRISPR/Cas9-based screen to identify host genes that, when edited, resulted in reduced flavivirus infection. Here, we validated nine human genes required for flavivirus infectivity, and these were associated with endoplasmic reticulum functions including translocation, protein degradation, and N-linked glycosylation. In particular, a subset of endoplasmic reticulum-associated signal peptidase complex (SPCS) proteins was necessary for proper cleavage of the flavivirus structural proteins (prM and E) and secretion of viral particles. Loss of SPCS1 expression resulted in markedly reduced yield of all Flaviviridae family members tested (West Nile, dengue, Zika, yellow fever, Japanese encephalitis, and hepatitis C viruses), but had little impact on alphavirus, bunyavirus, or rhabdovirus infection or the surface expression or secretion of diverse host proteins. We found that SPCS1 dependence could be bypassed by replacing the native prM protein leader sequences with a class I major histocompatibility complex (MHC) antigen leader sequence. Thus, SPCS1, either directly or indirectly via its interactions with host proteins, preferentially promotes the processing of specific protein cargo, and Flaviviridae have a unique dependence on this signal peptide processing pathway. SPCS1 and other signal processing pathway members could represent pharmacological targets for inhibiting infection by the expanding number of flaviviruses of medical concern.
Flaviviruses infect hundreds of millions of people annually, and no antiviral therapy is available 1,2 . We performed a genome-wide CRISPR/Cas9-based screen to identify host genes that, when edited, resulted in reduced flavivirus infection. Here, we validated nine human genes required for flavivirus infectivity, and these were associated with endoplasmic reticulum functions including translocation, protein degradation, and N-linked glycosylation. In particular, a subset of endoplasmic reticulum-associated signal peptidase complex (SPCS) proteins was necessary for proper cleavage of the flavivirus structural proteins (prM and E) and secretion of viral particles. Loss of SPCS1 expression resulted in markedly reduced yield of all Flaviviridae family members tested (West Nile, dengue, Zika, yellow fever, Japanese encephalitis, and hepatitis C viruses), but had little impact on alphavirus, bunyavirus, or rhabdovirus infection or the surface expression or secretion of diverse host proteins. We found that SPCS1 dependence could be bypassed by replacing the native prM protein leader sequences with a class I major histocompatibility complex (MHC) antigen leader sequence. Thus, SPCS1, either directly or indirectly via its interactions with host proteins, preferentially promotes the processing of specific protein cargo, and Flaviviridae have a unique dependence on this signal peptide processing pathway. SPCS1 and other signal processing pathway members could represent pharmacological targets for inhibiting infection by the expanding number of flaviviruses of medical concern.
We performed a genome-wide inhibition of West Nile virus (WNV)induced cell death screen using the CRISPR/Cas9 system [3] [4] [5] [6] [7] and lentiviruses targeting 19,050 genes (Extended Data Fig. 1a ). Whereas in the absence of lentivirus transduction cells did not survive WNV infection, colonies of lentivirus-transduced cells survived; single guide RNAs (sgRNAs) were amplified by PCR and sequenced. We identified 12 genes that were statistically enriched using MAGeCK 8 ( Supplementary Tables 1, 2 ). All 12 genes were endoplasmic reticulumassociated with annotated functions of carbohydrate modification, protein translocation and signal peptide processing, protein degradation, and heat shock response (Fig. 1a) .
In validation studies, editing of nine genes resulted in reduced WNV antigen expression following infection of 293T or HeLa cells ( Fig. 1a, b ) without causing cytotoxicity (Extended Data Fig. 1b ). We confirmed the efficiency of gene editing for the proteins for which we could obtain validated antibodies (Extended Data Fig. 1c ). Validated genes were tested for effects on related flaviviruses: Zika (ZIKV), Japanese encephalitis (JEV), dengue serotype 2 (DENV-2), and yellow fever (YFV) viruses. Editing of six of these genes reduced infection by all four flaviviruses ( Fig. 1c-f ). Editing of STT3A, SEC63, SPCS1, or SPCS3 resulted in decreased yields of WNV and JEV (Fig. 1g, h) . We observed less impact on unrelated positive-or negative-sense RNA viruses (Extended Data Fig. 1d ).
As pathogenic flaviviruses are transmitted by arthropods, we evaluated the roles of orthologues of these genes in insect cells. Silencing of Drosophila orthologues reduced infection by WNV and DENV-2 ( Fig. 2a, b ) without appreciably affecting cell viability ( Fig. 2c ). Decreased WNV infection was also observed in mosquito cells after gene silencing (Fig. 2d ). Depletion of Spase22-23 (orthologue of SPCS3) in adult Drosophila led to decreased WNV titres ( Fig. 2e ) and flies heterozygous for Spase12 (orthologue of SPCS1) showed reduced WNV infection ( Fig. 2f ). Overall, flavivirus infectivity in human and insect cells was dependent on analogous endoplasmic reticulum-associated genes.
Trans-complementation of gene-edited human cells with wild-type alleles rescued flavivirus infectivity (Extended Data Fig. 1e -g). Since we identified the genes encoding two (SPCS1 and SPCS3) of the five components of the Signal Peptidase Complex 9,10 , and found that insect SPCS genes also affected flavivirus infection, we focused our study on these genes. Gene silencing in human cells confirmed that SPCS genes were required for optimal flavivirus but not alphavirus infection (Extended Data Fig. 2 and data not shown).
We screened for clonal SPCS1 and SPCS3 knockout cells lines. Although we were unable to obtain SPCS3 −/− clonal lines, SPCS1 −/− 293T or Huh7.5 cell clones grew, with both alleles containing nonsense deletions ( Fig. 3a and Extended Data Fig. 3 ). WNV, DENV, JEV, YFV, and ZIKV failed to accumulate in the supernatants of SPCS1 −/− 293T cells ( Fig. 3c-f ), and WNV infectivity was restored in trans-complemented cells ( Fig. 3h ). However, SPCS1 −/− cells supported infection by alphaviruses, bunyaviruses, and rhabdoviruses ( Fig. 3i -k and Extended Data Fig. 3a ). To corroborate these findings, we tested SPCS1 −/− Huh7.5 cells and found reduced infection by WNV, ZIKV, JEV, and the related Flaviviridae member, hepatitis C virus (Extended Data Fig. 3e , f). In comparison, gene editing of the remaining SPCS genes, SEC11A and SEC11C, had minimal effects on infection (Extended Data Fig. 4 ).
To determine whether SPCS1 was required for viral translation, replication, or both, we used wild-type and loss-of-function 11 flavivirus replicons encoding reporter genes 12 (Fig. 3b and Extended Data Fig. 5 ). Transfection of control cells with replicon RNA resulted in low levels of reporter gene activity over the first several hours, which reflects translation of input viral RNA, whereas subsequent signal increases are due to RNA replication. In SPCS1 −/− cells, high levels of reporter gene expression were observed, indicating that viral RNA translation and replication remained largely intact.
We speculated that SPCS subunits, directly or indirectly, might regulate cleavage of the flavivirus polyprotein 13 . Flavivirus structural (prM and E) and non-structural (NS1 and NS4B) proteins are cleaved by unknown endoplasmic reticulum host signal peptidase(s) ( 
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resulted in decreased expression of NS1 and the accumulation of higher molecular mass bands ( Fig. 3o ). We detected lower levels of NS4B protein in SPCS1 −/− cells; in transfection studies with a tagged 2K-NS4B plasmid, a higher molecular mass band was observed. For NS1-NS2A and NS3, we did not detect aberrant cleavage (Extended Data Fig. 6 ). We also tested the effects on HCV E2 glycoprotein and found decreased levels in SPCS1 −/− cells (Extended Data Fig. 7 ). In comparison, alphavirus or bunyavirus glycoproteins, which also require endoplasmic reticulum processing 17, 18 , showed intact expression in SPCS1 −/− cells ( Fig. 3p and Extended Data Fig. 3b , c).
To isolate the effects of the SPCS complex from infection, we transfected a prM-E plasmid, which produces subviral particles (SVPs) 19 . Immunoblotting of cell lysates for E and prM proteins showed reduced levels and higher molecular mass bands in SPCS1-or SPCS3-deficient cells, and these changes correlated with a reduction in the number of secreted SVPs (Extended Data Fig. 8a -c). We tested whether cleavage of flavivirus protein signal sequences depended on SPCS1. We transfected WNV structural (capsid (C), prM, M, E) and secreted non-structural (NS1) genes with native or MHC class I (K b ) signal sequences into SPCS1 −/− cells, and evaluated protein expression ( Fig. 4) .
Expression of C protein from a C-prM-E plasmid was equivalent in control and SPCS1 −/− cells, although in the absence of the viral protease, C did not migrate at its normal size (Extended Data Fig. 8d ). However, cleavage of the downstream proteins prM and E was reduced in SPCS1 −/− cells. When NS2B-NS3 was supplied in trans, C was cleaved from prM-E and accumulated at the correct size in control and SPCS1 −/− cells. Thus, expression or cleavage of C is not affected by SPCS1.
We next evaluated expression of prM and M. When the native prM leader sequence was used, expression of prM and its furin-cleavage product M was reduced in SPCS1 −/− cells ( Fig. 4a, groups 1 and 3 ). Substitution of the K b leader rescued prM and M expression in SPCS1 −/− cells only when prM was on a separate plasmid ( Fig. 4a , group 2) but not as a prM-E plasmid ( Fig. 4a, group 4 ). Thus, specific leader sequences determine the dependence of prM and M protein expression on SPCS1, and downstream proteins can modulate processing efficiency.
When E was transfected, its expression was largely independent of SPCS1 or the K b leader sequence ( Fig. 4b , groups 1 and 2). When E was cloned downstream of prM, accumulation of E was not detected in SPCS1 −/− cells ( Fig. 4b , groups 3 and 4). This finding suggested that the native leader sequence of E was not cleaved in SPCS1 −/− cells when presented as an 'internal' leader sequence or that epistatic effects of the upstream prM protein reduced the stability of E protein. To test which of these possible explanations was correct, we performed 35 S pulse-chase studies in prM-E-transfected cells. In control cells, only a single E protein band was visible, indicating rapid prM-E cleavage. However, prM-E and E bands were both present in SPCS1 −/− cells (Fig. 4c , top) and remained in an endoplasmic reticulum-resident form (Fig. 4c, bottom) . A short 3-min 35 S pulse showed a delay in the cleavage of prM-E in SPCS1 −/− cells ( Fig. 4d ).
We assessed the expression of NS1, which also requires endoplasmic reticulum-dependent signal sequence cleavage. When NS1 was transfected into cells, SPCS1 was not required for expression ( Fig. 4e , group 1). When NS1 was cloned downstream of E (Fig. 4e , groups 2 and 3) or prM-E ( Fig. 4e , groups 4 and 5), NS1 levels were reduced in SPCS1 −/− cells. After blotting with an anti-NS1 monoclonal antibody, a 90-kDa band was visible in blots from SPCS1 −/− cells ( Fig. 4e, group 2) , which probably represented uncleaved E-NS1; this result was corroborated by blotting for E protein (Fig. 4b , groups 5 and 6). Thus, placement of the NS1 leader sequence into an internal position rendered it more dependent on SPCS1 for cleavage.
Flavivirus SVPs can be produced after transfection of prM and E on single or separate plasmids 20, 21 . Transfection of prM-E encoding native Hours after infection log 10 FFU ml -1 log 10 FFU ml -1 log 10 FFU ml -1 log 10 FFU ml -1 log 10 FFU ml -1 log 10 PFU ml -1
Control 
Hours after infection
Control Higher molecular mass bands (E hi , E med , and NS1 hi ) that react with anti-flavivirus monoclonal antibodies are indicated. One experiment of three is shown. p, 293T cells were infected with CHIKV or RVFV. Lysates were blotted with anti-CHIKV E2 or anti-RVFV Gn monoclonal antibodies. One experiment of two is shown. For gel source data, see Supplementary Fig. 1 . FFU, focus-forming unit; PFU, plaque-forming unit.
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or K b and native internal signal sequences resulted in loss of expression of prM and E or SVPs in SPCS1 −/− cells (Fig. 4f, groups 5 and 6) . When prM and E were co-transfected, the proteins were detected in SPCS1 −/− cell lysates (Fig. 4f, groups 1 and 2) and supernatant, albeit at lower levels. In SPCS1 −/− cells, prM negatively affected E but not NS1 production ( Fig. 4f (compare groups 1, 2, and 7) and Extended Data Fig. 8e ), possibly because of its chaperone-like function for E protein 20 . Defects in co-expression of prM and E in SPCS1 −/− cells were corrected by inserting the K b leader sequence in front of the prM gene ( Fig. 4f,  groups 3 and 4) . A 3-min 35 S pulse and immunoprecipitation experiment in SPCS1 −/− cells showed an uncleaved form of prM (Fig. 4g ).
To assess whether host surface proteins require SPCS1 for signal peptide processing, we profiled SPCS1 −/− Jurkat T cells. Whereas ten antigens showed no difference in surface expression, levels of CD49d-CD29, ULBP1, and HLA-E were reduced by two-to-threefold (Extended Data Fig. 9a-c) . A decrease in surface expression of ULBP1 Control Immunoprecipitates were untreated or treated with Endo H or PNGase F for 1 h at 37 °C. One experiment of two is shown. e, 293T cells were transfected with NS1, E-NS1, or prM-E-NS1 plasmids containing native viral or K b leaders. Blots of lysates or supernatants were probed with anti-NS1 monoclonal antibodies. One experiment of two is shown. f, 293T cells were transfected with prM + E, prM-E, or E plasmids containing viral or K b leaders. Left, blots of lysates were probed with anti-prM/M or anti-E monoclonal antibodies. One experiment of two is shown. Right, levels of SVPs in supernatant at 24 h. Data are pooled from independent experiments performed in triplicate (**P < 0.01, ***P < 0.001, ****P < 0.0001; unpaired t-test). g, 293T cells were transfected with prM-Flag. After 24 h, cells were labelled for 3 min with 35 S cysteinemethionine. Lysates were immunoprecipitated with anti-Flag protein monoclonal antibodies. h, Model of processing of flavivirus structural and non-structural proteins based on infection and transfection studies and the literature 14, 15 . Arrows indicate cleavage sites requiring SPCS1, sites affected by upstream SPCS1-dependent events, sites cleaved by the viral NS2B-NS3 protease, and sites cleaved via an SPCS1-independent pathway. For gel source data, see Supplementary Fig. 1 .
has been reported in cells deficient in SPCS1 or SPCS2 expression 22 , although this phenotype was not explored. In an unbiased approach, we analysed the secretome of SPCS1 −/− 293T cells by mass spectrometry. Of the approximately 245 secreted proteins identified, only 35 were downregulated in SPCS1 −/− cells, and the fold-changes were small (Extended Data Fig. 10 and Supplementary Table 4 ). We validated 3 of 5 as being reduced in supernatants of SPCS1 −/− cells (Supplementary Table 5 ). Despite profound effects on flavivirus protein processing, an absence of SPCS1 only modestly affected the expression of host proteins.
The differential requirement of SPCS1 for viral and host protein processing suggests that components of the SPCS complex in mammalian and probably insect cells facilitate the cleavage of particular signal peptides in specific contexts. There may be additional requirements for some viruses, as interactions between SPCS1 and the HCV NS2 and E2 proteins have been reported 23 .
A recent study performed an analogous CRISPR-based screen with WNV 24 . Endoplasmic reticulum-associated genes were identified that prevented WNV-induced cell death. We identified three of these genes (EMC4, EMC6, and SEL1L) , as did an siRNA screen 25 . Virtually all human gene 'hits' identified in our screen had insect orthologues required for optimal flavivirus infection. A subset of our genes were also identified in RNAi screens in Drosophila cells 26, 27 . The endoplasmic reticulum is a focal site in the flavivirus lifecycle because it supports translation, polyprotein processing, replication, and virion morphogenesis. The identification of host gene targets that are selectively required for flavivirus infection but not cell survival provides intriguing candidates for pharmacological inhibition.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.

METHODS
Cells and viruses.
Vero, BHK21, HeLa, U2OS, Huh7.5, and 293T cells were cultured at 37 °C in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS). C6/36 Aedes albopictus cells were cultured at 28 °C in L15 supplemented with 10% FBS and 25 mM HEPES pH 7.3. Drosophila DL1 and Aedes Aag2 cells were cultured at 28 °C in Schneider's medium supplemented with 10% FBS as described 28 . Jurkat cells were cultured at 37 °C in RPMI 1640 supplemented with 10% FBS and 10 mM HEPES pH 7.3. All cell lines were originally acquired from American Type Culture Collection or colleagues (Huh7.5) and were tested and judged free of mycoplasma contamination. The following viruses were used in screening and validation studies: WNV (New York 2000 and Kunjin), JEV (14-14-2 vaccine and Bennett strains), DENV-2 (16681 and New Guinea C strains), ZIKV (H/PF/2013), YFV (17D vaccine), CHIKV (2006 La Reunion OPY1), LACV (original strain), VSV (Indiana), HCV (J6/JFH), and SINV (Toto). With the exception of HCV (see below), all other viruses were propagated in BHK21, Vero, or C6/36 cells and titrated by standard plaque or focus-forming assays 29 . Viral growth analysis. 293T or Huh7.5 cells were infected with WNV (multiplicity of infection (MOI) 0.01), JEV (14-14-2 strain, MOI 0.05 or 0.5; Bennett strain, MOI 0.05), DENV-2 (MOI 3), YFV (MOI 1), ZIKV (MOI 0.05), CHIKV (MOI 0.01), SINV (MOI 0.01), RVFV (MOI 1), or VSV (MOI 0.01). After 2 h of incubation, cells were washed three times and samples were titrated on Vero cells. For HCV growth analysis, control and SPCS1 gene-edited Huh7.5 cells were inoculated at an MOI of 1 with virus derived from a growth-adapted JFH-1 infectious clone 30 . Cells were rinsed 6 h after infection to remove unbound virus and samples were collected every 24 h for 7 days. Viral titres in the supernatant were quantified by focus-forming assay, as described previously 31 . Pooled sgRNA screen and data analysis. A pooled library encompassing 122,411 different sgRNAs against 19,050 human genes was derived by the Zhang laboratory 32 and obtained from a commercial source (Addgene). The library was packaged using a lentivirus expression system and 293T cells were transfected using FugeneHD (Promega). Forty-eight hours after transfection, supernatants were collected, clarified by centrifugation (3,500 rpm × 20 min), filtered, and aliquotted for storage at −80 °C.
For the screen, we generated clonal 293T-Cas9 cells by transfecting the lentiCas9-Blast plasmid (Addgene 52962) using FugeneHD transfection reagent (Promega), blasticidin selection, and limiting dilution. These 293T-Cas9 cells were transduced with lentiviruses encoding individual sgRNAs at an MOI of 0.3. After selection with puromycin for 7 days, ~2 × 10 8 cells were infected with WNV (MOI of 1) and then incubated for 2-3 weeks. In parallel, untransduced 293T-Cas9 cells were infected to ensure virus-induced infection and cell death. The experiments were performed in parallel as either duplicate or triplicate technical replicates in two independent biological experiments.
Genomic DNA was extracted from the uninfected cells (5 × 10 7 ) or the cells (3 × 10 7 ) that survived WNV infection, and sgRNA sequences were amplified 5 , and subjected to next generation sequencing using an Illumina HiSeq 2500 platform. The sgRNA sequences against specific genes were recovered after removal of the tag sequences using the FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) and cutadapt 1.8.1. Gene validation. The cut-off for candidate gene 'hits' was made using a published computational tool (MAGeCK) 8 and reflected sequencing data showing multiple different sgRNAs per gene, the number of sequencing reads per gene, and the enrichment of a given sgRNA compared to the uninfected cell library ( Supplementary Tables 1, 2 ). From this, we identified 12 genes that showed statistically significant enrichment compared to uninfected cells. These candidate genes were tested for validation by using 3-5 independent sgRNAs per gene from the parent library and cloning them into the plasmid pSpCas9(BB)-2A-Puro (PX459) V2.0 (Addgene plasmid 62988). The control sgRNAs were used from the parent library. Plasmids were transfected into 293T or HeLa cells using FugeneHD transfection reagent and puromycin was added one day later. Three days later, puromycin was removed, and cells were allowed to recover for three additional days before infection with different viruses. VR-1248AF), LACV (807-31 and 807-33, gift from A. Pekosz). After washing, cells were incubated with an Alexa Fluor 647-conjugated goat anti-mouse or anti-human IgG (Invitrogen) for 1 h at 4 °C. Cells were fixed in 1% PFA in PBS, processed on a FACS Array (BD Biosciences), and analysed using FlowJo software (Tree Star).
Validation also was performed by an infectious virus yield assay. Bulk gene-edited 293T cells were infected with WNV (MOI 0.01) or JEV (MOI 0.5). Supernatants were collected at specific times after infection and focus-forming assays were performed in 96-well plates as described previously 36 . Following infection, cell monolayers were overlaid with 100 μl per well of medium (1 × DMEM, 4% FBS) containing 1% carboxymethylcellulose, and incubated for 22 h (WNV) or 36 h (JEV) at 37 °C with 5% CO 2 . Cells were then fixed by adding 100 μl per well of 1% PFA directly onto the overlay at room temperature for 40 min. Cells were washed twice with PBS, permeabilized (in 1 × PBS, 0.1% saponin, and 0.1% BSA) for 20 min, and incubated with antibodies specific for WNV (humanized E16 (ref. 33)) or JEV (mouse E18 (ref. 34)) E glycoprotein for 1 h at room temperature. After being rinsed twice, cells were incubated with species-specific HRPconjugated secondary antibodies (Sigma). After further washing, foci were developed by incubating in 50 μl per well of TrueBlue peroxidase substrate (KPL) for 10 min at room temperature, after which time cells were washed twice in water. Well images were captured using Immuno Capture software (Cell Technology Ltd), and foci counted using BioSpot software (Cell Technology Ltd). Insect cell and fly infections. dsRNAs were generated as described 37 . To silence genes using RNAi, insect cells were passaged into serum-free medium containing dsRNAs targeting the indicated genes. Cells were serum-starved for 1 h, after which complete medium was added and cells were incubated for 3 days. Cells were infected with WNV (Kunjin strain) at an MOI of 4 or DENV-2 (NGC strain) at an MOI of 1 for 30 h and then processed for microscopy with automated image analysis as described 38 . Control (hs>+) or Spcs3-depleted (hs>Spase22-23 IR (Bloomington)) 4-7-day-old female flies were heat shocked (37 °C) for 1 h for three consecutive days to deplete the gene of interest and challenged with WNV (Kunjin) (5 PFU) . At day 7 after infection, pools of 10 flies were crushed and titred by plaque assay. Three independent experiments were performed. Heterozygous flies (Spase12(EY10774)) were outcrossed to wild-type flies and either wild-type or Spase12 heterozygous sibling controls were challenged with WNV (Kunjin) for 7 days and groups of 5 flies were titred. siRNA treatments in human cells. Human U2OS cells were transfected with siRNAs against control, SPCS1, SPCS2, or SPCS3 genes for three days, infected with WNV (Kunjin) or DENV-2 (MOI 1) for 18 h, and then processed for microscopy with automated image analysis as described 38 . Replicon transfection and analysis. Two types of replicons were used. SP6-generated YFV replicons. The wild-type and NS5 polymerase mutant (GDD→GVD) YFV replicons (YF-FFLuc2A, wild-type and GVD) have been published previously 12 and were a gift from R. Kuhn. Capped replicon RNA was generated using SP6 polymerase with an mMESSAGE mMACHINE kit according to the manufacturer's instructions (Thermo Fisher Scientific). RNA was purified using an RNEasy kit (Qiagen) and 2 μg was transfected into control or SPCS1 −/− Huh7.5 cells using Lipofectamine 3000 according to the manufacturer's instructions (Thermo Fisher Scientific). At specified times, cells were collected, lysed, and processed for firefly luciferase activity using a commercial kit (Promega). Cleared lysates were tested for Fluc activity using the Dual-Luciferase Reporter Assay System (Promega) and the protein concentration was quantified using a BCA assay kit (ThermoFisher). Fluc activity (relative light units, RLU) was normalized by subtracting background luminescence of transfected cells collected at the time of transfection, then the adjusted RLU was divided by the total protein content (in μg) to yield RLU per μg protein.
cDNA launched WNV replicons. The construction of wild-type and NS5 polymerase mutant (GDD→GVD) WNV replicons (lineage I, strain New York 1999) was based on a previously described cDNA launched molecular clone system 39 . The backbone of this strategy, a plasmid containing a truncated WNV genome under the control of a CMV promoter (pWNV-backbone), was designed to be complemented via ligation of a structural gene DNA fragment; transfection of pWNV-backbone alone does not result in production of a self-replicating RNA molecule. Using overlap extension PCR and unique restriction endonuclease sites, pWNV-backbone was modified by the introduction of a fragment downstream of the CMV promoter encoding [5′UTR-cyclization sequence of capsid-FMDV2a proteasesignal sequence of E-NS1] to complement the NS2→NS5-3′UTR already present in the pWNV-backbone plasmid, generating the replicon plasmid pWNVI-rep. The reporter gene GFP was then cloned upstream of the FMDV2a protease sequence via a unique MluI site to generate pWNVI-rep-GFP. The construction and organization of this WNV lineage I replicon is analogous to a previously described lineage II WNV replicon (pWNVIIrep-GFP) 40 . Finally, QuikChange mutagenesis (Agilent Technologies) was used to delete the enhancer portion of the CMV immediate early enhancer/promoter, generating pWNVI-minCMV-rep-GFP, and to generate the
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The rCA120 (10 mg ml −1 ), Con-A and WGA were added to the peptide solution (36 μl and 10 μl, respectively). After incubation at room temperature, the mixture was transferred to a YM-10 Microcon filter unit. After centrifugation (14,000g) for 10 min and washing with binding buffer (100 μl), the filter unit was transferred to another tube. The peptides were released with the addition of PNGase (10 units) in 100 μl of ammonium bicarbonate buffer (50 mM) after incubation at 37 °C for 1.5 h. The enzyme addition and incubation was repeated and the peptides recovered with one wash of PNGase buffer. The peptides were acidified to 5% formic acid and desalted, labelled with TMT-6, and prepared for LC-MS as described above for the total pool of peptides. LC-MS analysis. LC-ESI/MS/MS analysis was conducted with a Q-Exactive Plus mass spectrometer coupled to an EASY-nanoLC 1000 system (Thermo-Fisher). For each Hp-RP fraction, 2 μl of sample was loaded onto a 75 μm i.d. × 25 cm Acclaim PepMap 100 RP column (Thermo-Fisher Scientific). Peptide separations were started with 95% mobile phase A (0.1% FA) for 5 min and increased to 30% B (100% ACN, 0.1% FA) over 180 min, followed by a 25-min gradient to 45% B, a 5-min gradient to 95% B and wash at 90% B for 7 min, with a flow rate of 300 nl min −1 . Full-scan mass spectra were acquired by the Orbitrap mass analyser in the mass-to-charge ratio (m/z) of 375-1,400 and with a mass resolving power set to 70,000. Fifteen data-dependent high-energy collisional dissociations were performed with a mass resolving power set to 35,000, a fixed first m/z of 100, an isolation width of 0.7 m/z, and the normalized collision energy (NCE) setting of 32. The maximum injection time was 50 ms for parent-ion analysis and 105 ms for product-ion analysis. Target ions already selected for MS/MS were excluded dynamically for 30 s. An automatic gain control target value of 3 × 10 6 ions was used for full MS scans and 10 5 ions for MS/MS scans. Peptide ions with charge states of one or greater than six were excluded from MS/MS interrogation. Protein identification and quantification with TMT. All raw data were processed using Proteome Discoverer (version 2.1.0.81, Thermo-Fischer Scientific). MS/MS spectra were searched with SequestHT engine against the human UniRef database (69,021 entries; version 2014_05), assuming the digestion enzyme was trypsin with a maximum of 2 missed cleavage allowed. The searches were performed with a fragment ion mass tolerance of 0.02 Da and a parent ion tolerance of 20 ppm. Deamidation of asparagine and glutamine, acetylation and TMT 6-plex derivatization of N termini and oxidation of methionine were specified in Proteome Discoverer as variable modifications. Iodoacetamide derivatization of cysteine and TMT 6-plex derivatization of lysine were specified as fixed modifications. Peptide spectral matches (PSM) were validated using percolator based on q-values at a 1% FDR 47 . Peptides were filtered to 1% FDR and grouped into proteins at 1% FDR as specified in Proteome Discoverer. The intensities of TMT reporter ions were determined with Proteome Discoverer at a mass tolerance of 0.01 Da and used for peptide quantifications. The median values of peptide intensities that can be assigned to a same protein was used to represent protein intensities. Peptide identifications that can be assigned to more than one protein were removed from protein quantification Proteomic Data Analysis. Normalization in protein ratios was applied in that the median ratios are log 2 0. Data analysis was performed with the free software environment for statistical computing and graphics, R (http://www.R-project. org). Gene ontology analysis was carried out using the Database for Annotation, Visualization and Integrated Discovery (DAVID) 48, 49 . Data from duplicated LC/ MS/MS analysis were first averaged and protein abundance ratios were log 2transformed before statistical analysis. A one-way ANOVA with Benjamini-Hochberg correction was performed to assess the statistical significance in protein abundance changes between wild type and SPCS1 −/− cells. Statistical analysis. No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Statistical significance was assigned when P values were <0.05 using GraphPad Prism Version 5.04. Viral antigen staining after expression of sgRNA was analysed using a one-way ANOVA adjusting for repeated measures with a Dunnett's multiple comparison test or with a Mann-Whitney test depending on the number of comparison groups. Analysis of levels of E protein in the supernatant from CRISPR-Cas9 gene edited cells was analysed by a one-way ANOVA. Analysis of siRNA in insect and human cells was performed using a Student's t-test or ANOVA. Spaces between the western blots indicate cropping to remove lanes that were not relevant to this experiment. Bottom, control or gene-edited 293T cells were infected with viruses and supernatants were harvested after infection for titration. Left, WNV (MOI 0.01, 72 h) or YFV (MOI 1, 72 h); right, SINV (MOI 0.01, 72 h), CHIKV (MOI 0.01, 36 h), VSV (MOI 0.01, 36 h), or RVFV (MOI 1, 72 h). Results are representative of two independent experiments. For gel source data, see Supplementary Fig. 1 .
